▶ 調査レポート

肺界面活性剤の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Lung Surfactants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。肺界面活性剤の世界市場2020年:メーカー別、地域別、種類・用途別 / Global Lung Surfactants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-12192資料のイメージです。• レポートコード:D0GIR-12192
• 出版社/出版日:GlobalInfoResearch / 2020年9月30日
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、肺界面活性剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。肺界面活性剤の種類別市場規模(気管内、注射可能)、用途別市場規模(病院、専門クリニック、回復センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Chiesi Farmaceutici、Lyomark Pharma、AbbVie、ONY Biotech、Aviva Systems Biology Corporation、Windtree Therapeutics
・地域別グローバル市場分析 2015年-2020年
・肺界面活性剤の北米市場(アメリカ、カナダ、メキシコ)
・肺界面活性剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・肺界面活性剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・肺界面活性剤の南米市場(ブラジル、アルゼンチン)
・肺界面活性剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:気管内、注射可能
・用途別分析:病院、専門クリニック、回復センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Lung Surfactants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Lung Surfactants sales will be xx in 2020 from Lung Surfactants million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Lung Surfactants market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Lung Surfactants industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Lung Surfactants and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Lung Surfactants market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Lung Surfactants market has been segmented into
Intratracheal
Injectable

By Application, Lung Surfactants has been segmented into:
Hospital
Special Clinic
Recovery Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lung Surfactants market presented in the report. This section sheds light on the sales growth of different regional and country-level Lung Surfactants markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lung Surfactants market.

The report offers in-depth assessment of the growth and other aspects of the Lung Surfactants market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Lung Surfactants Market Share Analysis
Lung Surfactants competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lung Surfactants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lung Surfactants sales, revenue and market share for each player covered in this report.

The major players covered in Lung Surfactants are:
Chiesi Farmaceutici
Lyomark Pharma
AbbVie
ONY Biotech
Aviva Systems Biology Corporation
Windtree Therapeutics

Among other players domestic and global, Lung Surfactants market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lung Surfactants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lung Surfactants, with price, sales, revenue and global market share of Lung Surfactants in 2018 and 2019.
Chapter 3, the Lung Surfactants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lung Surfactants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lung Surfactants market forecast, by regions, route of administration and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lung Surfactants sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Lung Surfactants Introduction
1.2 Market Analysis by Route of Administration
1.2.1 Overview: Global Lung Surfactants Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Intratracheal
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Lung Surfactants Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Overview of Global Lung Surfactants Market
1.4.1 Global Lung Surfactants Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Lung Surfactants Industry Impact
1.6.1 COVID-19 Potential Implications for the Lung Surfactants
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Lung Surfactants
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Chiesi Farmaceutici
2.1.1 Chiesi Farmaceutici Details
2.1.2 Chiesi Farmaceutici Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Chiesi Farmaceutici SWOT Analysis
2.1.4 Chiesi Farmaceutici Product and Services
2.1.5 Chiesi Farmaceutici Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lyomark Pharma
2.2.1 Lyomark Pharma Details
2.2.2 Lyomark Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lyomark Pharma SWOT Analysis
2.2.4 Lyomark Pharma Product and Services
2.2.5 Lyomark Pharma Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AbbVie SWOT Analysis
2.3.4 AbbVie Product and Services
2.3.5 AbbVie Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ONY Biotech
2.4.1 ONY Biotech Details
2.4.2 ONY Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ONY Biotech SWOT Analysis
2.4.4 ONY Biotech Product and Services
2.4.5 ONY Biotech Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aviva Systems Biology Corporation
2.5.1 Aviva Systems Biology Corporation Details
2.5.2 Aviva Systems Biology Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aviva Systems Biology Corporation SWOT Analysis
2.5.4 Aviva Systems Biology Corporation Product and Services
2.5.5 Aviva Systems Biology Corporation Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Windtree Therapeutics
2.6.1 Windtree Therapeutics Details
2.6.2 Windtree Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Windtree Therapeutics Product and Services
2.6.4 Windtree Therapeutics Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lung Surfactants Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lung Surfactants Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lung Surfactants Manufacturer Market Share in 2019
3.3.2 Top 6 Lung Surfactants Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lung Surfactants Sales, Revenue and Market Share by Regions
4.1.1 Global Lung Surfactants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lung Surfactants Revenue and Market Share by Regions (2015-2020)
4.2 North America Lung Surfactants Sales and Growth Rate (2015-2020)
4.3 Europe Lung Surfactants Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lung Surfactants Sales and Growth Rate (2015-2020)
4.5 South America Lung Surfactants Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lung Surfactants Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lung Surfactants Sales, Revenue and Market Share by Country
5.1.1 North America Lung Surfactants Sales and Market Share by Country (2015-2020)
5.1.2 North America Lung Surfactants Revenue and Market Share by Country (2015-2020)
5.2 United States Lung Surfactants Sales and Growth Rate (2015-2020)
5.3 Canada Lung Surfactants Sales and Growth Rate (2015-2020)
5.4 Mexico Lung Surfactants Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lung Surfactants Sales, Revenue and Market Share by Country
6.1.1 Europe Lung Surfactants Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lung Surfactants Revenue and Market Share by Country (2015-2020)
6.2 Germany Lung Surfactants Sales and Growth Rate (2015-2020)
6.3 UK Lung Surfactants Sales and Growth Rate (2015-2020)
6.4 France Lung Surfactants Sales and Growth Rate (2015-2020)
6.5 Russia Lung Surfactants Sales and Growth Rate (2015-2020)
6.6 Italy Lung Surfactants Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lung Surfactants Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lung Surfactants Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lung Surfactants Revenue and Market Share by Regions (2015-2020)
7.2 China Lung Surfactants Sales and Growth Rate (2015-2020)
7.3 Japan Lung Surfactants Sales and Growth Rate (2015-2020)
7.4 Korea Lung Surfactants Sales and Growth Rate (2015-2020)
7.5 India Lung Surfactants Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lung Surfactants Sales and Growth Rate (2015-2020)
7.7 Australia Lung Surfactants Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lung Surfactants Sales, Revenue and Market Share by Country
8.1.1 South America Lung Surfactants Sales and Market Share by Country (2015-2020)
8.1.2 South America Lung Surfactants Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lung Surfactants Sales and Growth Rate (2015-2020)
8.3 Argentina Lung Surfactants Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lung Surfactants Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lung Surfactants Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lung Surfactants Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lung Surfactants Sales and Growth Rate (2015-2020)
9.3 Turkey Lung Surfactants Sales and Growth Rate (2015-2020)
9.4 Egypt Lung Surfactants Sales and Growth Rate (2015-2020)
9.5 South Africa Lung Surfactants Sales and Growth Rate (2015-2020)
10 Market Segment by Route of Administration
10.1 Global Lung Surfactants Sales and Market Share by Route of Administration (2015-2020)
10.2 Global Lung Surfactants Revenue and Market Share by Route of Administration (2015-2020)
10.3 Global Lung Surfactants Price by Route of Administration (2015-2020)
11 Global Lung Surfactants Market Segment by Application
11.1 Global Lung Surfactants Sales Market Share by Application (2015-2020)
11.2 Global Lung Surfactants Revenue Market Share by Application (2015-2020)
11.3 Global Lung Surfactants Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lung Surfactants Sales, Revenue and Growth Rate (2021-2025)
12.2 Lung Surfactants Market Forecast by Regions (2021-2025)
12.2.1 North America Lung Surfactants Market Forecast (2021-2025)
12.2.2 Europe Lung Surfactants Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lung Surfactants Market Forecast (2021-2025)
12.2.4 South America Lung Surfactants Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lung Surfactants Market Forecast (2021-2025)
12.3 Lung Surfactants Market Forecast by Route of Administration (2021-2025)
12.3.1 Global Lung Surfactants Sales Forecast by Route of Administration (2021-2025)
12.3.2 Global Lung Surfactants Market Share Forecast by Route of Administration (2021-2025)
12.4 Lung Surfactants Market Forecast by Application (2021-2025)
12.4.1 Global Lung Surfactants Sales Forecast by Application (2021-2025)
12.4.2 Global Lung Surfactants Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Lung Surfactants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lung Surfactants by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lung Surfactants Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Lung Surfactants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 9. Chiesi Farmaceutici Lung Surfactants Major Business
Table 10. Chiesi Farmaceutici Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 11. Chiesi Farmaceutici SWOT Analysis
Table 12. Chiesi Farmaceutici Lung Surfactants Product and Services
Table 13. Chiesi Farmaceutici Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Lyomark Pharma Basic Information, Manufacturing Base and Competitors
Table 15. Lyomark Pharma Lung Surfactants Major Business
Table 16. Lyomark Pharma Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 17. Lyomark Pharma SWOT Analysis
Table 18. Lyomark Pharma Lung Surfactants Product and Services
Table 19. Lyomark Pharma Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. AbbVie Basic Information, Manufacturing Base and Competitors
Table 21. AbbVie Lung Surfactants Major Business
Table 22. AbbVie Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 23. AbbVie SWOT Analysis
Table 24. AbbVie Lung Surfactants Product and Services
Table 25. AbbVie Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. ONY Biotech Basic Information, Manufacturing Base and Competitors
Table 27. ONY Biotech Lung Surfactants Major Business
Table 28. ONY Biotech Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 29. ONY Biotech SWOT Analysis
Table 30. ONY Biotech Lung Surfactants Product and Services
Table 31. ONY Biotech Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Aviva Systems Biology Corporation Basic Information, Manufacturing Base and Competitors
Table 33. Aviva Systems Biology Corporation Lung Surfactants Major Business
Table 34. Aviva Systems Biology Corporation Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 35. Aviva Systems Biology Corporation SWOT Analysis
Table 36. Aviva Systems Biology Corporation Lung Surfactants Product and Services
Table 37. Aviva Systems Biology Corporation Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Windtree Therapeutics Basic Information, Manufacturing Base and Competitors
Table 39. Windtree Therapeutics Lung Surfactants Major Business
Table 40. Windtree Therapeutics Lung Surfactants Total Revenue (USD Million) (2018-2019)
Table 41. Windtree Therapeutics SWOT Analysis
Table 42. Windtree Therapeutics Lung Surfactants Product and Services
Table 43. Windtree Therapeutics Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Lung Surfactants Sales by Manufacturer (2018-2019) (K Units)
Table 45. Global Lung Surfactants Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Lung Surfactants Sales by Regions (2015-2020) (K Units)
Table 47. Global Lung Surfactants Sales Market Share by Regions (2015-2020)
Table 48. Global Lung Surfactants Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Lung Surfactants Sales by Countries (2015-2020) (K Units)
Table 50. North America Lung Surfactants Sales Market Share by Countries (2015-2020)
Table 51. North America Lung Surfactants Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Lung Surfactants Revenue Market Share by Countries (2015-2020)
Table 53. Europe Lung Surfactants Sales by Countries (2015-2020) (K Units)
Table 54. Europe Lung Surfactants Sales Market Share by Countries (2015-2020)
Table 55. Europe Lung Surfactants Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Lung Surfactants Sales by Regions (2015-2020) (K Units)
Table 57. Asia-Pacific Lung Surfactants Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Lung Surfactants Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Lung Surfactants Sales by Countries (2015-2020) (K Units)
Table 60. South America Lung Surfactants Sales Market Share by Countries (2015-2020)
Table 61. South America Lung Surfactants Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Lung Surfactants Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Lung Surfactants Sales by Countries (2015-2020) (K Units)
Table 64. Middle East & Africa Lung Surfactants Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Lung Surfactants Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Lung Surfactants Revenue Market Share by Countries (2015-2020)
Table 67. Global Lung Surfactants Sales by Type (2015-2020) (K Units)
Table 68. Global Lung Surfactants Sales Share by Type (2015-2020)
Table 69. Global Lung Surfactants Revenue by Type (2015-2020) (USD Million)
Table 70. Global Lung Surfactants Revenue Share by Type (2015-2020)
Table 71. Global Lung Surfactants Sales by Application (2015-2020) (K Units)
Table 72. Global Lung Surfactants Sales Share by Application (2015-2020)
Table 73. Global Lung Surfactants Sales Forecast by Regions (2021-2025) (K Units)
Table 74. Global Lung Surfactants Market Share Forecast by Regions (2021-2025)
Table 75. Global Lung Surfactants Sales Forecast by Type (2021-2025) (K Units)
Table 76. Global Lung Surfactants Market Share Forecast by Type (2021-2025)
Table 77. Global Lung Surfactants Sales Forecast by Application (2021-2025)
Table 78. Global Lung Surfactants Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lung Surfactants Picture
Figure 2. Global Sales Market Share of Lung Surfactants by Route of Administration in 2019
Figure 3. Intratracheal Picture
Figure 4. Injectable Picture
Figure 5. Lung Surfactants Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Special Clinic Picture
Figure 8. Recovery Center Picture
Figure 9. Global Lung Surfactants Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Lung Surfactants Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Lung Surfactants Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Lung Surfactants Sales Market Share by Manufacturer in 2019
Figure 30. Global Lung Surfactants Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Lung Surfactants Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Lung Surfactants Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Lung Surfactants Revenue Market Share by Regions (2015-2020)
Figure 37. Global Lung Surfactants Revenue Market Share by Regions in 2018
Figure 38. North America Lung Surfactants Sales and Growth Rate (2015-2020)
Figure 39. Europe Lung Surfactants Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Lung Surfactants Sales and Growth Rate (2015-2020)
Figure 41. South America Lung Surfactants Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Lung Surfactants Sales and Growth Rate (2015-2020)
Figure 43. North America Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Lung Surfactants Sales Market Share by Countries (2015-2020)
Figure 45. North America Lung Surfactants Sales Market Share by Countries in 2018
Figure 46. North America Lung Surfactants Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Lung Surfactants Revenue Market Share by Countries in 2018
Figure 48. United States Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Lung Surfactants Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Lung Surfactants Revenue Market Share by Countries in 2019
Figure 54. Germany Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Lung Surfactants Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Lung Surfactants Revenue Market Share by Regions 2019
Figure 62. China Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Lung Surfactants Sales Market Share by Countries in 2019
Figure 69. South America Lung Surfactants Revenue Market Share by Countries in 2019
Figure 70. Brazil Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Lung Surfactants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Lung Surfactants Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Lung Surfactants Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Lung Surfactants Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Lung Surfactants Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Lung Surfactants Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Lung Surfactants Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Lung Surfactants Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Lung Surfactants Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Lung Surfactants Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Lung Surfactants Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Lung Surfactants Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel